Fidelity MSCI Health Care Index ETF (FHLC US) – Investment Proposition

Fidelity MSCI Health Care Index ETF (FHLC) presents diversified access to U.S. health-care equities spanning pharmaceuticals, biotechnology, equipment, services, and life-sciences tools, aligning the portfolio with long-duration growth from innovation and demographics rather than purely cyclical demand. The strategy pursues sector-level returns through a broad, rules-based basket, accepting exposure to binary outcomes in drug development in exchange for defensiveness from non-discretionary care and recurring procedures. Return drivers include clinical pipelines, pricing power, utilization trends, and productivity gains from technology; income is present in select industries but varies widely. Style exposures often blend quality and growth, with relative resilience in slowdowns and potential headwinds during risk-on rallies led by highly cyclical sectors or when reimbursement pressure rises. Portfolio roles include a defensive-growth satellite, a thematic health-innovation sleeve within equities, or a diversification anchor for balanced mandates seeking lower earnings cyclicality. Suitable investors include long-horizon allocators aiming to smooth equity volatility and research-led strategies seeking exposure to medical innovation. A key risk to monitor is policy and reimbursement uncertainty, which can alter profitability and accelerate dispersion among subsectors.

To explore FHLC in more depth, visit our ETF analytics platform for institutional-grade insights — including performance and risk metrics, correlations, sensitivities, and factor exposure: https://www.etfstrategy.com/etf/FHLC_US